FDA Inspection
AstraZeneca ABAstraZeneca AB – FDA Inspection, Dec 1, 2022
Record Details
This FDA Inspection record concerns AstraZeneca AB, with an inspection on December 1, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- AstraZeneca AB
- Inspection Date
- December 1, 2022
- Product Type
- Drugs
View Company Profile
ID · 65d12a99-cde6-4429-91ea-7d6b624af95f
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1248349
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of AstraZeneca AB
7| Date | Classification | Office | Project area |
|---|---|---|---|
| October 11, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 30, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 7, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 26, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 29, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for AstraZeneca AB
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.